pipeline

A robust pipeline in pursuit of transformative therapies

section-desktop-image section-mobile-image
Qartemi® (varnimcabtagene autoleucel, var-cel): commercialised in India.
www.cellspectrum.com
Autologous CD19 CAR-T cell therapy Qartemi® is used in treatment of relapsed and refractory Non Hodgkin’s Lymphoma (NHL). Varnimcabtagene autoleucel, arising out of our collaboration with Hospital Clinic Barcelona, is approved in Spain and India.

Products in Development

Immuneel Therapeutics Private Limited
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.